Involvement of osteopontin and its signaling molecule CD44 in clinicopathological features of adult T cell leukemia

Leukemia Research

Volumn 35, Issue 11, 2011, Pages 1484-1490

  Chagan Yasutan, Haorile ^a   Tsukasaki, Kunihiro ^b   Takahashi, Yayoi ^c   Oguma, Shigeru ^d   Harigae, Hideo ^c   Ishii, Naoto ^a   Zhang, Jing ^e   Fukumoto, Manabu ^f   Hattori, Toshio ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

^d TAKEDA GENERAL HOSPITAL   (Japan)

^e Fuso Pharmaceutical Industries   (Japan)

^f TOHOKU UNIVERSITY   (Japan)

Author keywords

ATL; CD44; CD44v6; Immunohistochemical staining; OPN; Prognostic factors

Indexed keywords

HERMES ANTIGEN; INTEGRIN; LACTATE DEHYDROGENASE; OSTEOPONTIN;

ADULT; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKEMOGENESIS; LYMPH NODE; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN; T CELL LEUKEMIA; TISSUE DISTRIBUTION;

ADULT; AGED; ANTIGENS, CD44; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LYMPH NODES; MALE; MIDDLE AGED; OSTEOPONTIN; SIGNAL TRANSDUCTION; SKIN;

EID: 80053943966     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.05.011     Document Type: Article

References (43)

1. Poiesz B.J., Ruscetti F.W., Gazdar A.F., et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77(12):7415.
2. Hinuma Y., Nagata K., Hanaoka M., et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981, 78(10):6476.
3. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977, 50:481.
4. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-1987). Br J Haematol 1991, 79:428.
5. Tsukasaki K., Hermine O., Bazarbachi A., et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 2008, 27:453.
6. Hattori T., Uchiyama T., Toibana T., Takatsuki K., Uchino H. Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood 1981, 58(3):645.
7. Suzushima H., Asou N., Nishimura S., et al. Double-negative (CD4- CD8-) T cells from adult T-cell leukemia patients also have poor expression of the T-cell receptor alpha beta/CD3 complex. Blood 1993, 81(4):1032.
8. Kikuchi M., Mitsui T., Matsui N., et al. T-cell malignancies in adults: histopathological studies of lymph nodes in 110 patients. Jpn J Clin Oncol 1979, 9:407.
9. Arisawa K., Soda M., Endo S., et al. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 2000, 85(3):319.
10. Grassmann R., Dengler C., Müller-Fleckenstein I., et al. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpes virus saimiri vector. Proc Natl Acad Sci USA 1989, 86:3351.
11. Wano Y., Hattori T., Matsuoka M., et al. Interleukin 1 gene expression in adult T-cell leukemia. J Clin Invest 1987, 80:911.
12. Chung H.K., Young H.A., Goon P.K., et al. Activation of interleukin-13 expression in T cells from HTLV-I-infected individuals and in chronically infected cell lines. Blood 2003, 102:4130.
13. Chen J., Petrus M., Bryant B.R., et al. Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism. Blood 2008, 111(10):5163.
14. Satou Y., Yasunaga J., Yoshida M., Matsuoka M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci USA 2006, 103(3):720.
15. Katagiri Y.U., Sleeman J., Fujii H., et al. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 1999, 59(1):219.
16. Green P.M., Ludbrook S.B., Miller D.D., Horgan C.M., Barry S.T. Structural elements of the osteopontin SVVYGLR motif important for the interaction with alpha(4) integrins. FEBS Lett 2001, 503(1):75.
17. Bellahcène A., Castronovo V., Ogbureke K.U., Fisher L.W., Fedarko N.S. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer 2008, 8(3):212.
18. Chagan-Yasutan H., Saitoh H., Ashino Y., et al. Persistent elevation of plasma osteopontin levels in HIV patients despite highly active antiretroviral therapy. Tohoku J Exp Med 2009, 218:285.
19. McAllister S.S., Gifford A.M., Greiner A.L., et al. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 2008, 133(6):994.
20. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990, 61(7):1303.
21. Weber G.F., Ashkar S., Glimcher M.J., Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996, 271(5248):509.
22. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003, 4(1):33.
23. Stauder R., Eisterer W., Thaler J., Günthert U. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 1995, 85(10):2885.
24. Wielenga V.J., van der Neut R., Offerhaus G.J., Pals S.T. CD44 glycoproteins in colorectal cancer: expression, function, and prognostic value. Adv Cancer Res 2000, 77:169.
25. Zhang J., Yamada O., Matsushita Y., Chagan-Yasutan H., Hattori T. Transactivation of human osteopontin promoter by human T-cell leukemia virus type 1-encoded Tax protein. Leuk Res 2009, 34:763.
26. Zhang J., Yamada O., Kida S., Matsushita Y., Yamaoka S., et al. Identification of CD44 as a downstream target of noncanonical NF-kB pathway activated by Human T-cell leukemia virus type 1-encoded Tax protein. Virology 2011, 413:244.
27. Chagan-Yasutan H., Shiratori B., Siddiqi U.R., et al. The increase of plasma galectin-9 in a patient with insulin allergy: a case report. Clin Mol Allergy 2010, 8(1):12.
28. Chen R., Sigdel T.K., Li L., et al. Differentially expressed RNA from Public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions. PLoS Comput Biol 2010, 6(9):e1000940.
29. Shibata H., Yamakoshi H., Sato A., et al. Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo. Cancer Sci 2009, 100(5):956.
30. Gao C., Guo H., Downey L., et al. Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells. Carcinogenesis 2003, 24(12):1871.
31. Takemoto M., Yokote K., Nishimura M., et al. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. Arterioscler Thromb Vasc Biol 2000, 20(3):624.
32. Hattori T., Asou N., Suzushima H., et al. Leukaemia of novel gastrointestinal T-lymphocyte population infected with HTLV-I. Lancet 1991, 337(8733):76.
33. Tominaga T., Suzuki M., Saeki H., et al. Establishment of an activated macrophage cell line. A-THP-1, and its properties. Tohoku J Exp Med 1998, 186(2):99.
34. Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study-Lymphoma Study Group (1984-1987). Leuk Res 1991;15:81.
35. Weiss J.M., Renkl A.C., Maier C.S., et al. Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J Exp Med 2001, 194(9):1219.
36. Powell J.A., Thomas D., Barry E.F., et al. Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML. Blood 2009, 114(23):4859.
37. Horst E., Meijer C.J., Radaszkiewicz T., et al. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Leukemia 1990, 4(8):595.
38. Castellano G., Malaponte G., Mazzarino M.C., et al. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression. Clin Cancer Res 2008, 14(22):7470.
39. Hsu H.P., Shan Y.S., Lai M.D., Lin P.W. Osteopontin-positive infiltrating tumor-associated macrophages in bulky ampullary cancer predict survival. Cancer Biol Ther 2010, 10(2):144.
40. Shirono K., Hattori T., Hata H., Nishimura H., Takatsuki K. Profiles of expression of activated cell antigen on peripheral blood and lymph node cells from different clinical stages of adult T-cell leukemia. Blood 1989, 73:1664.
41. Solinas G., Germano G., Mantovani A., Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukocyte Biol 2009, 86(5):1065.
42. Steidl C., Lee T., Shah S.P., et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010, 362(10):875.
43. Duff M.D., Mestre J., Maddali S., et al. Analysis of gene expression in the tumor-associated macrophage. J Surg Res 2007, 142(1):119.